Skip Navigation

European Heart Journal 2002 23(19):1529-1537; doi:10.1053/euhj.2002.3169
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ronner, E.
Right arrow Articles by Simoons, M.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ronner, E.
Right arrow Articles by Simoons, M.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies. A single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction

E. Ronner, R.T. van Domburg, M.J.B.M. van den Brand, P.J. de Feyter, D.P. Foley, W.J. van der Giessen, P.W. Serruys and M.L. Simoonsf1

Erasmus Medical Center, Rotterdam, The Netherlands

revised January 3, 2002; accepted January 8, 2002

Abstract

In order to study the safety of ‘rescue’ strategies in the treatment of patients with failed thrombolysis, all 548 patients admitted with evolving myocardial infarction to the Thoraxcenter, Rotterdam, from January 1997 until April 1999 were reviewed. Of these patients, 49% had received thrombolysis. Of patients treated with thrombolysis and not referred from other hospitals (n=154) 36% received rescue therapy for failed thrombolysis. Three rescue therapies were used after failed thrombolysis: percutaneous coronary intervention (74%), retreatment with thrombolysis (39%) and platelet glycoprotein (GP) IIb/IIIa receptor blockers (53%), often in combination. Platelet GP IIb/IIIa receptor blockers were administered in 64% of patients treated with rescue percutaneous coronary intervention. Major bleeding occurred in 14% of all thrombolysis treated patients, and in 30% of patients who received multiple rescue therapies. Bleeding was related to heparin usage and platelet GP IIb/IIIa receptor blockers, as was the insertion of catheters for percutaneous coronary intervention or intra-aortic balloon pumps. Major bleeding resulted in one death due to a ruptured ventricle, one haemorrhagic stroke, and three cases of tamponade for which surgery was needed. Four of these patients had received combination rescue therapy. Rescue therapy is a widely used strategy for failed thrombolysis, but is associated with a high bleeding rate. Alternative reperfusion strategies to avoid failed thrombolysis should be considered in high risk patients. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Key Words: Thrombolysis, infarction, angioplasty, streptokinase, plasminogen activators, haemorrhage

f1 Correspondence: Prof. Dr Maarten L. Simoons, Thoraxcenter, H 560, Academisch Ziekenhuis Rotterdam, Dijkzigt, Dr. Molenwaterplein 40, 3015 GD, Rotterdam, The Netherlands.

References

  1. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  2. Langer A, Krucoff MW, Klootwijk P. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST segment monitoring substudy. J Am Coll Cardiol. 1998;31:783–789[Abstract/Free Full Text]
  3. Davies CH, Ornerod OJM. Failed coronary thrombolysis. Lancet. 1999;351:1191–1196
  4. Am J Cardiol. 1994;74:172–174[CrossRef][ISI][Medline]
  5. Baim DS, Diver DJ, Knatterud GL. PTCA ‘salvage’ for thrombolytic failures: implications from TIMI 2A. Circulation. 1988;78:II-112
  6. White HD, Cross DB, Williams BF. ‘Rescue’ thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol. 1995;75:172–174[CrossRef][ISI][Medline]
  7. Becker RC. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion. Clin Cardiol. 1994;17:3–13[ISI][Medline]
  8. Simoons ML, Arnout J, Van den Brand M, Nyssen K, Verstraete M. Retreatment with Alteplase for early signs of reoclusion after thrombolysis. The European Cooperative Study Group. Am J Cardiol. 1993;71:524–528[CrossRef][ISI][Medline]
  9. Miller JM, Smalling R, Ohman EM. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global use of strategies to open occluded coronary arteries. Am J Cardiol. 1999;84:779–784[CrossRef][ISI][Medline]
  10. Muhlestein JB, Karagounis LA, Treehan S. ‘Rescue’ utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol. 1997;30:1724–1729
  11. N Engl J Med. 1997;336:1689–1696[Abstract/Free Full Text]
  12. N Engl J Med. 1994;330:956–961[Abstract/Free Full Text]
  13. Lancet. 1998;352:87–92[ISI][Medline]
  14. Lancet. 2001;357:1905–1914[CrossRef][ISI][Medline]
  15. Ronner E, Zijnen P, Altmann E. Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction. A phase II dose escalation, randomized, double-blind study. Eur Heart J. 2000;18:1530–1536
  16. Antman EM, Giugliano RP, Gibson MC. Abciximab facilitates the rate and extent of thrombolysis. Results of the thrombolyis in myocardial infarction (TIMI) 14 trial. Circulation. 1999;99:2720–2732[Abstract/Free Full Text]
  17. Jong P, Cohen EA, Batchelor W. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction. Am Heart J. 2001;141:218–225[CrossRef][ISI][Medline]
  18. Schröder R, Dissman R, Brüggemann T. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute AMI. J Am Coll Cardiol. 1994;24:389–391
  19. Bär F, Vainer J, Stevenhagen J. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol. 2000;36:51–58[Abstract/Free Full Text]
  20. Hasdai, D, Euro Heart Survey, 2001
  21. Stenestrand, U, Wallentin, L
  22. Simes RJ, Topol EJ, Holmes DR. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial perfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation. 1995;91:1905[Free Full Text]
  23. Ohman EM, Califf RM, Topol EJ. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 1990;82:781–791[Abstract/Free Full Text]
  24. Topol EJ, Califf RM, George BS. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317:581–588[Abstract]
  25. BMJ. 1991;302:555–560[ISI][Medline]
  26. Ellis SG, De Silva RE, Heyndrickx G. Randomized comparison of rescue angioplasty with conservative management of patients with early failure thrombolysis for AMI. Circulation. 1994;90:2280–2284[Abstract/Free Full Text]
  27. Ross AM, Lundergan CF, Rohrbeck SC. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1998;31:1511–1517[Abstract/Free Full Text]
  28. Gibson CM, Cannon CP, Greene RM. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. Am J Cardiol. 1997;80:16–21[CrossRef][ISI][Medline]
  29. Tebbe U, Michels R, Adgey AAJ. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS equivalence trial. Comparison trial of saruplase and streptokinase (COMASS) investigators. J Am Coll Cardiol. 1998;31:487–493[Abstract/Free Full Text]
  30. Schroder R, Wegscheider K, Schroder K. Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial. J Am Coll Cardiol. 1996;26:1657–1667
  31. Betriu A, Califf RM, Bosch X. Recurrent ischemia after thrombolysis: importance of associated clinical findings. Gusto-1 investigators. J Am Coll Cardiol. 1998;31:94–102[Abstract/Free Full Text]
  32. N Engl J Med. 1993;329:1615–1622[Abstract/Free Full Text]
  33. Bär F, Vainer J, Stevenhagen J. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol. 2000;36:51–58[Abstract/Free Full Text]
  34. Ellis GE, Da Silva ER, Spaulding CM, Nobuyoshi M, Weiner B, Talley D. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J. 2000;139:1046–1053[CrossRef][ISI][Medline]
  35. Grines CL, Browne KF, Marco J. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673–679[Abstract/Free Full Text]
  36. Bär F, Vainer J, Stevenhagen J. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol. 2000;36:51–58[Abstract/Free Full Text]
  37. Kontny F, Dale J, Abildgaard U, Pedersen TR. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study. J Am Coll Cardiol. 1997;30:962–969[Abstract]
  38. Simoons ML, Arnold AE. Tailored thrombolytic therapy. A perspective. Circulation. 1993;88:2556–2564[Abstract/Free Full Text]
  39. Lancet. 1994;343:311–322[CrossRef][ISI][Medline]
  40. Zijlstra F, de Boer MJ, Hoomtje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–684[Abstract/Free Full Text]
  41. Abbottsmith CW, Topol EJ, George BS. Fate of patients with acute AMI with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol. 1990;16:770–778[Abstract]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
P Di Pasquale
Rescue therapy for failed thrombolysis
Eur. Heart J., April 2, 2003; 24(8): 785 - 785.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
V. S. Mahadevan, D. McCarty, and A. A. J. Adgey
Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies
Eur. Heart J., October 1, 2002; 23(19): 1490 - 1491.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ronner, E.
Right arrow Articles by Simoons, M.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ronner, E.
Right arrow Articles by Simoons, M.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?